慢性阻塞性肺疾病合并肺癌體液中的潛在生物標(biāo)志物研究進(jìn)展

【摘要】 慢性阻塞性肺疾病（COPD）并發(fā)肺癌患者的數(shù)量與日俱增，并且COPD合并肺癌的患者相較于普通肺癌患者往往具有更明顯的臨床癥狀及更差的預(yù)后。因此，基于人體尿液、痰液、唾液、支氣管肺泡灌洗液等體液，尋找一種新的生物標(biāo)志物實(shí)現(xiàn)COPD合并肺癌的早診、早治十分重要。

【關(guān)鍵詞】 肺癌 COPD 生物標(biāo)志物 體液

Research Progress of Potential Biomarkers in Body Fluids of Patients with Chronic Obstructive Pulmonary Disease Complicated with Lung Cancer/CHEN Guoqing， MA Hongxia. //Medical Innovation of China， 2023， 20（10）： -165

[Abstract] The number of patients with chronic obstructive pulmonary disease （COPD） complicated with lung cancer is increasing day by day， and patients with COPD complicated with lung cancer often have more obvious clinical symptoms and worse prognosis than ordinary lung cancer patients. Therefore， based on human urine， sputum， saliva， bronchoalveolar lavage fluid and other body fluids， it is very important to find a new biomarker to realize the early diagnosis and treatment of COPD complicated with lung cancer.

[Key words] Lung cancer COPD Biomarkers Body fluids

First-author's address： The Fourth Clinical College of Xinjiang Medical University， Urumqi 830000， China

doi：10.3969/j.issn.1674-4985.2023.10.038

慢性阻塞性肺疾?。–OPD）是一種以持續(xù)性氣道氣流受限為特征的呼吸系統(tǒng)疾病。（剩余10706字）